These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 3307584)

  • 1. Biosynthetic human insulin improves postprandial glucose excursions in type I diabetics.
    Gulan M; Gottesman IS; Zinman B
    Ann Intern Med; 1987 Oct; 107(4):506-9. PubMed ID: 3307584
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Improved postprandial metabolic control after subcutaneous injection of a short-acting insulin analog in IDDM of short duration with residual pancreatic beta-cell function.
    Pampanelli S; Torlone E; Ialli C; Del Sindaco P; Ciofetta M; Lepore M; Bartocci L; Brunetti P; Bolli GB
    Diabetes Care; 1995 Nov; 18(11):1452-9. PubMed ID: 8722069
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of insulin analogue B9AspB27Glu and soluble human insulin in insulin-treated diabetes.
    Kang S; Owens DR; Vora JP; Brange J
    Lancet; 1990 Feb; 335(8685):303-6. PubMed ID: 1967767
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of the anatomical region used for insulin injections on glycemia in type I diabetes subjects.
    Bantle JP; Neal L; Frankamp LM
    Diabetes Care; 1993 Dec; 16(12):1592-7. PubMed ID: 8299455
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Insulin bolus given by sprinkler needle: effect on absorption and glycaemic response to a meal.
    Edsberg B; Herly D; Hildebrandt P; Kühl C
    Br Med J (Clin Res Ed); 1987 May; 294(6584):1373-6. PubMed ID: 3109661
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Improved postprandial glycemic control with insulin aspart. A randomized double-blind cross-over trial in type 1 diabetes.
    Lindholm A; McEwen J; Riis AP
    Diabetes Care; 1999 May; 22(5):801-5. PubMed ID: 10332685
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of subcutaneous soluble human insulin and insulin analogues (AspB9, GluB27; AspB10; AspB28) on meal-related plasma glucose excursions in type I diabetic subjects.
    Kang S; Creagh FM; Peters JR; Brange J; Vølund A; Owens DR
    Diabetes Care; 1991 Jul; 14(7):571-7. PubMed ID: 1914797
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Insulin lispro: a review of its pharmacological properties and therapeutic use in the management of diabetes mellitus.
    Wilde MI; McTavish D
    Drugs; 1997 Oct; 54(4):597-614. PubMed ID: 9339963
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prolonged efficacy of short acting insulin Lispro in combination with human ultralente in insulin-dependent diabetes mellitus.
    Burge MR; Waters DL; Holcombe JH; Schade DS
    J Clin Endocrinol Metab; 1997 Mar; 82(3):920-4. PubMed ID: 9062507
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The effect of the insulin analog lispro on nighttime blood glucose control in type 1 diabetic patients.
    Ahmed AB; Home PD
    Diabetes Care; 1998 Jan; 21(1):32-7. PubMed ID: 9538967
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pramlintide reduces postprandial glucose excursions when added to regular insulin or insulin lispro in subjects with type 1 diabetes: a dose-timing study.
    Weyer C; Gottlieb A; Kim DD; Lutz K; Schwartz S; Gutierrez M; Wang Y; Ruggles JA; Kolterman OG; Maggs DG
    Diabetes Care; 2003 Nov; 26(11):3074-9. PubMed ID: 14578242
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ultra-rapid BioChaperone Lispro improves postprandial blood glucose excursions vs insulin lispro in a 14-day crossover treatment study in people with type 1 diabetes.
    Andersen G; Meiffren G; Lamers D; DeVries JH; Ranson A; Seroussi C; Alluis B; Gaudier M; Soula O; Heise T
    Diabetes Obes Metab; 2018 Nov; 20(11):2627-2632. PubMed ID: 29923294
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Improved postprandial glycemic control in patients with type 2 diabetes from subcutaneous injection of insulin lispro with hyaluronidase.
    Hompesch M; Muchmore DB; Morrow L; Ludington E; Vaughn DE
    Diabetes Technol Ther; 2012 Mar; 14(3):218-24. PubMed ID: 22136324
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Improved glycemic control with insulin aspart: a multicenter randomized double-blind crossover trial in type 1 diabetic patients. UK Insulin Aspart Study Group.
    Home PD; Lindholm A; Hylleberg B; Round P
    Diabetes Care; 1998 Nov; 21(11):1904-9. PubMed ID: 9802741
    [TBL] [Abstract][Full Text] [Related]  

  • 15. alpha-Dicarbonyls increase in the postprandial period and reflect the degree of hyperglycemia.
    Beisswenger PJ; Howell SK; O'Dell RM; Wood ME; Touchette AD; Szwergold BS
    Diabetes Care; 2001 Apr; 24(4):726-32. PubMed ID: 11315838
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Treatment with human insulin (recombinant DNA) in diabetic subjects pretreated with pork or beef insulin: first results of a multicenter study.
    Beyer J; Enzmann F; Lauerbach M; Althoff P; Bachmann W; Brandstetter K; Cordes U; Dannehl A; Düntsch G; Haas R
    Diabetes Care; 1982; 5 Suppl 2():140-8. PubMed ID: 6765526
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prandial glycaemia after a carbohydrate-rich meal in type I diabetic patients: using the rapid acting insulin analogue [Lys(B28), Pro(B29)] human insulin.
    Heinemann L; Heise T; Wahl LC; Trautmann ME; Ampudia J; Starke AA; Berger M
    Diabet Med; 1996 Jul; 13(7):625-9. PubMed ID: 8840095
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A double-blind crossover trial comparing human insulin (recombinant DNA) with animal insulins in the treatment of previously insulin-treated diabetic patients.
    Clark AJ; Wiles PG; Leiper JM; Knight G; Adeniyl-Jones RO; Watkins PJ; Ward JD; MacCuish AC; Keen H; Jones RH
    Diabetes Care; 1982; 5 Suppl 2():129-34. PubMed ID: 6765523
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Meal composition is a determinant of lispro-induced hypoglycemia in IDDM.
    Burge MR; Castillo KR; Schade DS
    Diabetes Care; 1997 Feb; 20(2):152-5. PubMed ID: 9118763
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Optimal administration of lispro insulin in hyperglycemic type 1 diabetes.
    Rassam AG; Zeise TM; Burge MR; Schade DS
    Diabetes Care; 1999 Jan; 22(1):133-6. PubMed ID: 10333914
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.